Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse L Rodriguez

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Infection and Immunity|July 25, 2012
Increased chain length promotes pneumococcal adherence and colonizationJesse L Rodriguez, Ankur B Dalia, Jeffrey N Weiser
Human Gene Therapy. Clinical Development|July 2, 2013
Lessons learned from the clinical development and market authorization of GlyberaLaura M Bryant, Devin M Christopher, April R Giles, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2024
Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastomaNannan Li, Jesse L Rodriguez, Yibo Yin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2022
Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumorsYibo Yin, Jesse L Rodriguez, Nannan Li, et al.
Molecular Therapy Oncolytics|October 12, 2018
Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine GliomasYibo Yin, Alina C Boesteanu, Zev A Binder, et al.
Blood|January 6, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapiesAlberto Carturan, Mathew G Angelos, Puneeth Guruprasad, et al.
Cell|June 15, 2026
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBMNelson F Freeburg, Daniel Chafamo, Gayathri Konanur Gopikrishna, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Infection and Immunity|July 25, 2012
Increased chain length promotes pneumococcal adherence and colonizationJesse L Rodriguez, Ankur B Dalia, Jeffrey N Weiser
Human Gene Therapy. Clinical Development|July 2, 2013
Lessons learned from the clinical development and market authorization of GlyberaLaura M Bryant, Devin M Christopher, April R Giles, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2024
Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastomaNannan Li, Jesse L Rodriguez, Yibo Yin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2022
Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumorsYibo Yin, Jesse L Rodriguez, Nannan Li, et al.
Molecular Therapy Oncolytics|October 12, 2018
Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine GliomasYibo Yin, Alina C Boesteanu, Zev A Binder, et al.
Blood|January 6, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapiesAlberto Carturan, Mathew G Angelos, Puneeth Guruprasad, et al.
Cell|June 15, 2026
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBMNelson F Freeburg, Daniel Chafamo, Gayathri Konanur Gopikrishna, et al.
Pageof 1